Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/19/1991 | EP0432697A2 BU-4146T antibiotic |
06/19/1991 | EP0432695A2 Amino acid derivatives |
06/19/1991 | EP0432677A1 N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives |
06/19/1991 | EP0432648A2 Isatine derivatives, their preparation and use |
06/19/1991 | EP0432638A1 Combination preparations comprising chloramphenicol, gentamicin and nystatin as active substances for topical treatment of skin inflammation diseases |
06/19/1991 | EP0432630A2 Antitumor agent |
06/19/1991 | EP0432595A1 Novel peptides, their preparation and their application in medicaments |
06/19/1991 | EP0432537A2 Supersulfated heparins |
06/19/1991 | EP0432527A2 Pradimicin derivatives |
06/19/1991 | EP0432510A1 Process for the preparation of genetic vectors for the nerve growth factor expression in eukaryotic cells |
06/19/1991 | EP0432494A2 Pour-on formulations effective for the control of internal and external parasites of homothermic animals |
06/19/1991 | EP0432442A1 ACAT inhibitors |
06/19/1991 | EP0432209A1 Phenylpyrrolic compounds used as drugs, their preparation and application. |
06/19/1991 | EP0282495B1 Xylometazolin-containing pharmaceuticals |
06/19/1991 | EP0248047B1 Medicament with anti-tumoral action containing hexadecylphosphocholine |
06/19/1991 | EP0093770B1 The use of retinoids and minoxidil (2,4-diamino-6-piperidino-pyrimidine-3-oxide) to increase the rate of growth of human scalp hair and to treat certain types of alopecias |
06/19/1991 | CN1052306A Pharmaceutically active cns compounds |
06/19/1991 | CN1052305A Pyridine derivatives, pharmaceutical compositions containing them and process for preparing same |
06/19/1991 | CA2071972A1 Pharmaceutical compositions for treating or preventing retroviral infections |
06/19/1991 | CA2071480A1 Piperidine compounds and a pharmaceutical composition |
06/19/1991 | CA2047246A1 1-triacontanol derivatives |
06/19/1991 | CA2032427A1 Benzodiazepines analogs |
06/19/1991 | CA2032393A1 Ltb4 synthesis inhibitors |
06/19/1991 | CA2032373A1 Formulation |
06/19/1991 | CA2032259A1 Hiv protease inhibitors useful for the treatment of aids |
06/19/1991 | CA2032226A1 Benzodiazepine analogs |
06/19/1991 | CA2032222A1 Benzodiazepine analogs doe treating panic syndrome and for directly inducing analgesia |
06/19/1991 | CA2031593A1 Compositions of antiallergics and antihistamines and methods for their use |
06/19/1991 | CA2031586A1 Process for preparing an optically active cyclobutane nucleoside |
06/18/1991 | US5025038 Process for the preparation of antimicrobial formulations of 2-(alkylthio)ethanamine hydrohalides |
06/18/1991 | US5025035 Method of treating depression |
06/18/1991 | US5025034 Prostaglandins |
06/18/1991 | US5025033 Cholinesterase inhibitors for treating brain disorders |
06/18/1991 | US5025032 For ischemia or inflammation of brain or nervous system |
06/18/1991 | US5025031 Aryl and aryloxyalkyl sulfamate esters useful as anticonvulsants |
06/18/1991 | US5025029 Method for augmenting fetal hemoglobin |
06/18/1991 | US5025028 Asthma |
06/18/1991 | US5025024 Therapeutically active fluoro-substituted compound |
06/18/1991 | US5025022 Method of treating or preventing schizophrenia and/or psychosis using S-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamides and thiobenzamides |
06/18/1991 | US5025020 Effective against drug resistant strains |
06/18/1991 | US5025019 Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
06/18/1991 | US5025018 Central nervous system injury treatment with opiate-receptor antagonist |
06/18/1991 | US5025017 Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates |
06/18/1991 | US5025016 Pyrimidine-thioalkyl pyridine derivatives, medicaments containing these compounds, and method of treatment |
06/18/1991 | US5025015 Antisecretory and antiulcer agents |
06/18/1991 | US5025013 Benzopyran derivatives, their preparation and pharmaceutical compositions containing them |
06/18/1991 | US5025012 Cardiovascular disorders; antiischemic agents |
06/18/1991 | US5025011 Calcium-antigonist and beta-blocking properties; antihypertensives; vasodilators |
06/18/1991 | US5025010 Benzothiazinone derivatives, and pharmaceuticals containing them |
06/18/1991 | US5025009 Novel benzazepine derivatives |
06/18/1991 | US5025005 Preventive or therapeutic agents for circulatory diseases, allergic disorders; antineoplastic agent; inhibitor for platelet activating factor |
06/18/1991 | US5025003 Isoprenoid phosphinylformic acid squalene synthetase inhibitors |
06/18/1991 | US5025000 Phosphorus-containing HMG-CoA reductase inhibitor compounds |
06/18/1991 | US5024998 Pharmaceutical formulations for parenteral use |
06/18/1991 | US5024997 Aqueous solution with sweetener and cyclodextrin derivate; for oral administration |
06/18/1991 | US5024995 Phospholipids and proteins; free of carbohydrates, cholesterol and triglycerides |
06/18/1991 | US5024843 Time-release tablet; unaffected by gastrointestinal environment |
06/18/1991 | US5024833 Combined interferon/antiestrogen therapy for treatment of breast cancer |
06/18/1991 | US5024743 Prophylaxis and therapy of infectious diseases |
06/18/1991 | CA1284997C 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and their use as antidepressants |
06/18/1991 | CA1284996C Theophyllinemethyldithiolan and theophyllinemethyldithianyl derivatives |
06/18/1991 | CA1284995C Cephalosporin compounds and processes for preparing the same |
06/18/1991 | CA1284994C Cephalosporin salts and injectable compositions |
06/18/1991 | CA1284993C Cephalosporins and processes for their preparation |
06/18/1991 | CA1284953C 2-alkoxy-n-(1-azabicyclo[2.2.2] oct-3-yl) benzamides and thiobenzamides in amethod for alleviating emesis caused by non-platinum anticancer drugs |
06/18/1991 | CA1284952C Use of specific n-methyl-d-aspartate receptor antagonists in the prevention and treatment of neurodegeneration |
06/18/1991 | CA1284951C Cell protection with oxypurinol |
06/18/1991 | CA1284950C Method for using diltiazem, verapamil or nifedipine for treating stroke |
06/18/1991 | CA1284949C Pharmaceutical composition containing progesterone |
06/17/1991 | WO1991008737A2 Pharmacologically active amide carboxylate derivatives |
06/17/1991 | CA2072018A1 Pharmacologically active amide carboxylate derivatives |
06/16/1991 | WO1991009036A1 Beta-lactam derivatives |
06/16/1991 | CA2071885A1 Beta-lactam derivatives |
06/16/1991 | CA2032282A1 2-substituted 4-(3-alkyl-5-tert.-butyl-4-hydroxyphenyl)thiazoles, processes for their preparation, pharmaceuticals containing them and their use |
06/16/1991 | CA2032227A1 Reversal of female sexual phenotype in poultry |
06/16/1991 | CA2032212A1 Compounds of the diterpene type |
06/16/1991 | CA2032180A1 Halogenated olefins, processes for their preparation and their use as pesticides especially against insects and mites |
06/15/1991 | WO1991009002A1 Process for the preparation of vinyl ethers |
06/15/1991 | CA2032176A1 Alkylamino- and alkylaminoalkyl diarylketones, a process for their preparation and their use as medicaments |
06/15/1991 | CA2032132A1 Use of naphthoxazines |
06/15/1991 | CA2032034A1 Antiviral new peptides |
06/14/1991 | WO1991008739A1 Growth arrest of proliferating cells by transglutaminase inhibitors |
06/14/1991 | CA2071550A1 Growth arrest of proliferating cells by transglutaminase inhibitors |
06/14/1991 | CA2032104A1 Serotonin antagonists, preparation thereof and medications containing them |
06/14/1991 | CA2032092A1 Antitumor agent |
06/14/1991 | CA2032049A1 Medicaments |
06/13/1991 | WO1991009041A1 Novel platinum (ii) complex and drug for treating malignant tumor |
06/13/1991 | WO1991009030A1 2-substituted 4,5-diphenyl-imidazoles |
06/13/1991 | WO1991009015A1 Muscarinic receptor antagonists |
06/13/1991 | WO1991009014A1 Muscarinic receptor antagonists |
06/13/1991 | WO1991009013A1 Muscarinic receptor antagonists |
06/13/1991 | WO1991008973A1 Container for fan-folded sheets |
06/13/1991 | WO1991008751A1 The use of gibberellins for the treatment of prostatitis and psoriasis |
06/13/1991 | WO1991008215A1 Process for the preparation of 2-amino-9-(2,3,5-tri-0-benzyl-beta-d-arabinofuranosyl)adenine and novel intermediates |
06/13/1991 | WO1991008211A1 IMIDAZO[1,2-a]PYRIDINYLALKYL COMPOUNDS FOR TREATMENT OF NEUROTOXIC INJURY |
06/13/1991 | WO1991008205A1 N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals |
06/13/1991 | WO1991008203A1 Novel thiazolidinone derivatives, pharmaceutical compositions containing them and process for preparing same |
06/13/1991 | WO1991008191A1 Novel potent inducers of terminal differentiation and method of use thereof |
06/13/1991 | WO1991008189A1 Polyhydroxy-1,4-naphthoquinones and a pharmaceutical preparation as protector of myocardium under ischemia and reperfusion based on them |
06/13/1991 | WO1991008009A1 Dialysis and flushing solution for intraperitoneal administration |